0.2151
-0.0067
(-3.02%)
At close: January 10 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2020
Total Revenue
1,476,630.0000
1,266,375.0000
1,049,471.0000
491,063.5250
Operating Expense
1,723,045.0000
1,434,305.0000
1,295,432.0000
519,651.2030
Operating Income
-246,415.0000
-167,930.0000
-245,961.0000
-28,587.6780
Net Non Operating Interest Income Expense
-19,385.0000
-15,985.0000
-11,404.0000
-2,533.1800
Other Income Expense
16,665.0000
184.0000
-1,302,330.0000
-290.6840
Pretax Income
-249,135.0000
-183,731.0000
-1,559,695.0000
-31,411.5420
Tax Provision
1,202.0000
2,695.0000
1,862.0000
--
Net Income Common Stockholders
-102,694.0000
-57,773.0000
-270,127.0000
-31,411.5420
Diluted NI Available to Com Stockholders
-31,660.0000
-57,773.0000
-270,127.0000
-31,411.5420
Basic EPS
-0.79
-0.61
-6.50
-0.46
Diluted EPS
-0.86
-0.63
-6.50
-0.46
Basic Average Shares
133,350.5000
94,889.0000
41,600.0000
68,159.5320
Diluted Average Shares
184,598.0000
294,590.0000
41,600.0000
68,159.5320
Total Operating Income as Reported
-246,415.0000
-167,930.0000
-1,560,913.0000
-28,587.6780
Total Expenses
1,723,045.0000
1,434,305.0000
1,295,432.0000
519,651.2030
Net Income from Continuing & Discontinued Operation
-102,694.0000
-57,773.0000
-270,127.0000
-31,411.5420
Normalized Income
-114,848.9400
-58,115.0700
760,891.7300
-31,411.5420
Interest Expense
19,385.0000
15,985.0000
11,404.0000
2,533.1800
Net Interest Income
-19,385.0000
-15,985.0000
-11,404.0000
-2,533.1800
EBIT
-229,750.0000
-167,746.0000
-1,548,291.0000
-28,878.3620
EBITDA
-143,211.0000
-81,071.0000
-1,461,002.0000
-28,083.1900
Reconciled Depreciation
86,539.0000
86,675.0000
87,289.0000
795.1720
Net Income from Continuing Operation Net Minority Interest
-102,694.0000
-57,773.0000
-270,127.0000
-31,411.5420
Total Unusual Items Excluding Goodwill
15,386.0000
433.0000
-1,305,087.0000
--
Total Unusual Items
15,386.0000
433.0000
-1,305,087.0000
--
Normalized EBITDA
-158,597.0000
-81,504.0000
-155,915.0000
-28,083.1900
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
Tax Effect of Unusual Items
3,231.0600
90.9300
-274,068.2700
--
12/31/2020 - 4/6/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TOI The Oncology Institute, Inc.
0.3017
+0.94%
GRST Ethema Health Corporation
0.0005
0.00%
IONM Assure Holdings Corp.
0.0770
+140.62%
NUTX Nutex Health Inc.
30.88
-2.56%
JRSS JRSIS Health Care Corporation
0.1670
0.00%
TOIIW The Oncology Institute, Inc.
0.0156
0.00%
MSGP MedSmart Group Inc.
0.0001
0.00%
AVAH Aveanna Healthcare Holdings Inc.
4.5100
-3.43%
UNVC Univec, Inc.
0.0021
-8.70%
PTLKF PT Lippo Karawaci Tbk
0.0090
0.00%